Extra-fine particles improve lung delivery of inhaled steroids in infants: a study in an upper airway model.

BACKGROUND The particles of a new hydrofluoroalkane-134a (HFA)-beclomethasone dipropionate (BDP) metered-dose inhaler (Qvar; 3M Pharmaceuticals; St. Paul, MN) are considerably smaller than those of chlorofluorocarbon (CFC)-BDP. This may improve lung deposition in infants who inhale nasally and have irregular breathing patterns and small airways. AIM To compare the dose delivered to the lungs of HFA-BDP and CFC-BDP at different breathing patterns using an upper airway model of an infant. METHODS An anatomically correct upper airway model of a 9-month-old child with an open nasal airway was connected to an impactor and breathing simulator. HFA-BDP, 100 microg, and CFC-BDP, 100 micro g, were delivered to the model through a detergent-coated, small-volume spacer. The total dose leaving the model (lung dose), its particle size distribution, and median mass aerodynamic diameter (MMAD) were assessed during simulated tidal breathing with tidal volumes (VTs) of 50 mL, 100 mL, and 200 mL, and 30 breaths/min. Dose was expressed as percentage of nominal dose. RESULTS Lung doses for HFA-BDP were 25.4%, 26.5%, and 30.7% compared with 6.8%, 4.8%, and 2.1% for CFC-BDP at VTs of 50 mL, 100 mL, and 200 mL, respectively. The dose of particles < 2.1 microm to the lung for HFA-BDP was 23 to 28% compared with 0.6 to 0.8% for CFC-BDP. The lung dose of CFC-BDP mainly consisted of particles between 2.1 microm and 4.7 microm. MMAD for HFA-BDP was 1.2 microm, and 2.6 to 3.3 microm for CFC-BDP depending on VT. The lung dose for CFC-BDP decreased significantly with increasing VT. HFA-BDP lung dose did not alter significantly with VT. CONCLUSIONS In this infant model study, the use of HFA-BDP with a high dose of particles < 2.1 microm improves the dose delivered to the lungs substantially. Furthermore, the large proportion of extra-fine particles in HFA-BDP results in lung doses less dependent on breathing pattern compared with CFC-BDP.

[1]  M. Mellon.  Efficacy of budesonide inhalation suspension in infants and young children with persistent asthma. Budesonide Inhalation Suspension Study Group. , 1999, The Journal of allergy and clinical immunology.

[2]  J. Wildhaber,et al.  Washing plastic spacers in household detergent reduces electrostatic charge and greatly improves delivery. , 1999, The European respiratory journal.

[3]  T. Martonen.  Mathematical model for the selective deposition of inhaled pharmaceuticals. , 1993, Journal of pharmaceutical sciences.

[4]  W. Fokkens,et al.  The Sophia Anatomical Infant Nose-Throat (Saint) model: a valuable tool to study aerosol deposition in infants. , 2001, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

[5]  R. Iles,et al.  Crying significantly reduces absorption of aerosolised drug in infants , 1999, Archives of disease in childhood.

[6]  J. Wildhaber,et al.  Electrostatic charge on a plastic spacer device influences the delivery of salbutamol. , 1996, The European respiratory journal.

[7]  J. Wildhaber,et al.  High‐percentage lung delivery in children from detergent‐treated spacers , 2000, Pediatric pulmonology.

[8]  W. Hop,et al.  Aerosol delivery from spacers in wheezy infants: a daily life study. , 2000, The European respiratory journal.

[9]  D. Swift,et al.  Particle deposition and resistance in the noses of adults and children. , 1991, The European respiratory journal.

[10]  C. Leach,et al.  Improved airway targeting with the CFC-free HFA-beclomethasone metered-dose inhaler compared with CFC-beclomethasone. , 1998, The European respiratory journal.

[11]  M. Newhouse,et al.  Reliable salbutamol administration in 6‐ to 36‐month‐old children by means of a metered dose inhaler and aerochamber with mask , 1989, Pediatric pulmonology.

[12]  W. Finlay,et al.  In vitro comparison of beclomethasone and salbutamol metered-dose inhaler aerosols inhaled during pediatric tidal breathing from four valved holding chambers. , 1998, Chest.

[13]  P. Sly,et al.  The influence of age on aerosol deposition in children with cystic fibrosis. , 1994, The European respiratory journal.

[14]  J. Wildhaber,et al.  Inhalation therapy in asthma: nebulizer or pressurized metered-dose inhaler with holding chamber? In vivo comparison of lung deposition in children. , 1999, The Journal of pediatrics.

[15]  Swift Dl.  Age-related scaling for aerosol and vapor deposition in the upper airways of humans. , 1989 .

[16]  A. Tal,et al.  Deposition pattern of radiolabeled salbutamol inhaled from a metered-dose inhaler by means of a spacer with mask in young children with airway obstruction. , 1996, The Journal of pediatrics.

[17]  Dolovich Ma.  Influence of inspiratory flow rate, particle size, and airway caliber on aerosolized drug delivery to the lung. , 2000 .

[18]  P. Barry,et al.  The effect of delay, multiple actuations and spacer static charge on the in vitro delivery of budesonide from the Nebuhaler. , 1995, British journal of clinical pharmacology.

[19]  G. Coates,et al.  Efficiency of aerosol medication delivery from a metered dose inhaler versus jet nebulizer in infants with bronchopulmonary dysplasia , 1996, Pediatric pulmonology.

[20]  M. Everard.  Studies using radiolabelled aerosols in children. , 1994, Thorax.

[21]  R H Cummings,et al.  Pressurized metered dose inhalers: chlorofluorocarbon to hydrofluoroalkane transition-valve performance. , 1999, The Journal of allergy and clinical immunology.

[22]  D. Pavia,et al.  Effects of various inhalation modes on the deposition of radioactive pressurized aerosols. , 1982, European journal of respiratory diseases. Supplement.

[23]  W. Busse,et al.  Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellant. , 1999, The Journal of allergy and clinical immunology.